fashion -WSS

fashion

author：explore 2025-09-30 21:22:16 - browse：8375

Red blood cells flow in an artery biotech — coverage from STAT — Adobe

PHILADELPHIA — An investigational drug aimed at preventing strokes significantly reduced the risk of bleeding compared with a commonly used blood thinner for stroke prevention, showing potential to be a safer alternative for patients.

Among patients with atrial fibrillation, an abnormal heart rhythm that increases the risk of stroke, abelacimab, developed by Anthos Therapeutics, cut the overall risk of bleeding by 67% compared to rivaroxaban, the blood thinner sold as Xarelto by Janssen Pharmaceuticals.

The treatment, injected monthly, also reduced the risk of major bleeding events by 74% and gastrointestinal bleeding by 93%, according to Phase 2 results presented here Sunday at the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Criminal prosecution for violating HIPAA: an emerging threat

focus

leisure time

hotspot

WSS

Bird flu: Don't repeat Covid's 'health versus the economy' framing

'Revelatory' study finds a smoking impact that remains after quitting

Case highlights the risks of experimental stem cell therapy

KalVista pill reduced swelling 'attacks' caused by genetic disease

Addiction experts warn against a second 'war on drugs'

What we’ve learned from the Aduhelm mess

entertainment

fashion

hotspot

Jerome Adams on the need for new antivirals for Covid

Addiction experts warn against a second 'war on drugs'

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Private equity deals in Medicare Advantage declines

ChatGPT in medicine: STAT answers readers' burning questions

The dental labor crisis is a moment of opportunity

New air purifier tech could be key to improving indoor air quality

Biden report: The neurospychology of memory and aging

New air purifier tech could be key to improving indoor air quality

For Medicare Advantage, Democrats want stronger protections around AI

hotspot

Venture capitalist Bob Kocher on the state of digital health

Analysis of pharma R&D ranks Novo Nordisk, J&J above their peers

What should King Charles tell the public about his cancer?

With measles on the rise, a personal story of a devastating disease

Vaccine advisory panel ACIP left half staffed by HHS

KalVista pill reduced swelling 'attacks' caused by genetic disease

focus

leisure time

hotspot

hotspot